COMPANY
Clinical Phase 2
Keywords: oncology small molecule tumors melanoma glioblastoma Ovary Cancer Pancreatic Cancer ENB003
Location: Long Island City, NY · source · Oct 14, 2026
Profile checked Oct 10, 2026
Timeline
- Trial start 1: ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT04205227 | ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors | 1 | Unknown status (ClinicalTrials.gov) | Feb 18, 2020 | Jan 1, 2026 (estimated) |